KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 156 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $590,000 | +12.4% | 11,776 | -22.3% | 0.40% | +22.2% |
| Q4 2014 | $525,000 | +54.4% | 15,162 | +45.7% | 0.32% | +51.9% |
| Q3 2014 | $340,000 | -15.0% | 10,408 | -0.2% | 0.21% | -10.1% |
| Q2 2014 | $400,000 | -5.0% | 10,426 | -1.7% | 0.24% | -9.2% |
| Q1 2014 | $421,000 | +4.7% | 10,603 | -1.6% | 0.26% | +7.8% |
| Q4 2013 | $402,000 | -20.7% | 10,773 | -3.2% | 0.24% | +0.8% |
| Q3 2013 | $507,000 | +70.7% | 11,130 | +1.1% | 0.24% | +65.1% |
| Q2 2013 | $297,000 | – | 11,004 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,382,722 | $69,344,000 | 3.43% |
| Versant Venture Management, LLC | 70,376 | $3,529,356,000 | 3.10% |
| AlpInvest Partners B.V. | 29,731 | $1,491,000 | 2.79% |
| Partner Investment Management, L.P. | 29,178 | $1,463,000 | 2.20% |
| PFM Health Sciences, LP | 1,242,509 | $62,312,000 | 1.72% |
| Aureus Asset Management, LLC | 130,307 | $6,535,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 444,999 | $22,317,000 | 1.49% |
| HealthCor Management, L.P. | 425,000 | $21,314,000 | 1.02% |
| Redmile Group, LLC | 225,062 | $11,287,000 | 1.01% |
| REGENTATLANTIC CAPITAL LLC | 174,454 | $8,749,000 | 0.77% |